April 25, 2019Open Access

Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis

Key Points

Key points are not available for this paper at this time.

Abstract

This patient-level meta-analysis of BRPC patients treated with neoadjuvant FOLFIRINOX showed a favorable median OS, resection rate, and R0-resection rate. These results need to be assessed in a randomized trial.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Quisette P. Janssen

Directorate-General for Interpretation

Stefan Buettner

Erasmus MC Cancer Institute

Mustafa Suker

Erasmus MC Cancer Institute

Journals

JNCI Journal of the National Cancer Institute

ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)

Actions

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study